Mahidol University; Butantan Institute; Mount Sinai: NDV-HXP-S

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Butanvac

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 3 Trials

Phase 2: 3 Trials

Phase 3: 1 Trial


This vaccine is not yet approved.

Registered Trials